Showing posts with label Brain. Show all posts
Showing posts with label Brain. Show all posts

Tuesday, August 10, 2010

Moral of the story: Ever wonder how your roommate can sleep through fire alarms, car horns, and other crazy loud things?  Surprise surprise (not really) you brain hears everything but some block those stimuli.

Source: AMA Morning Rounds 8/10/2010


Some brains may be specifically wired to block out noise during the night.

USA Today (8/10, Steinberg) asks, "Why can some people sleep through car alarms and thunderstorms when others wake up at the sound of footsteps?" Harvard researchers now "believe they've found the answer tucked in sleep spindles, or bursts of brain activity that occur only during sleep."
        Before reaching that conclusion, investigators conducted a "three-night study," inviting "12 volunteers who reported being deep and healthy sleepers into a sleep lab with a comfy queen-size bed outfitted with enormous speakers at the headboard," Time(8/10, Park) reports. The "researchers recorded the participants' brain waves as they slept normally the first night, and then on subsequent nights as they were bombarded with 14 different noises...which were played at progressively louder volumes." The team "paid particular attention to the patterns generated by the thalamus, a region deep in the brain that processes incoming visual and auditory stimuli."
        The team had surmised that "the thalamus might generate" the "sleep spindles as a way to prevent sensory input (such as loud noise) from reaching the sleeping brain," HealthDay (8/9, Phillips) reported. According to the paper in Current Biology, "people with higher rates of spindle rhythms were consistently less likely to awake in response to these noises." But, it's still not "completely clear if sleep spindles are directly interfering with sound transmission to the brain, although that's the current hypothesis."

Monday, July 26, 2010

Several strategies may be worth trying to prevent Alzheimer's

Moral of the story: While there are many things that do NOT work (such as ginseng and those brain games), here are a few strategies that be worth exploring to help prevent alzheimer's disease.

Source: AMA Morning Rounds 7/26/2010


Several strategies may be worth trying to prevent Alzheimer's.

In the first of a related series of articles focusing on Alzheimer's disease, the Los Angeles Times (7/26, Roan) reports that nothing has been found to prevent Alzheimer's disease, according to an "assessment was issued by a National Institutes of Health task force at an April meeting." However, "several healthy and inexpensive strategies are clearly worth trying, say neurologists and Alzheimer's researchers." Currently, "the strategies with the most support are regular physical activity, a Mediterranean diet, and high levels of cognitive engagement."
        Early-stage programs may be valuable for those recently diagnosed with Alzheimer's. The Los Angeles Times(7/26, Ogilvie) discusses the value of "early stage programs" to assist patients newly diagnosed with Alzheimer's and their families. Such programs provide "a safe place to be heard; educational seminars and day trips; and access to practical advice on matters, such as financial planning and end-of-life care," as well as alleviate the isolation such a devastating diagnosis brings. In fact, according to Steven Arnold, a professor of psychiatry and neurology at the University of Pennsylvania and the director of the Penn Memory Center, "interacting with people who are sensitive to what they're going through...can comfort people with the disease and help alleviate that isolation, as well as the depression that the Alzheimer's Assn. estimates affects 20%-40% of patients."
        Five medications have been approved to treat cognitive symptoms of Alzheimer's. The Los Angeles Times (7/26, Roan) reports, "Five medications have been approved to treat the cognitive symptoms of Alzheimer's disease." The medicines, which include Namenda (memantine), Razadyne (reminyl galantamine), Exelon (rivastigmine), Aricept (donepezil), and Cognex (tacrine) "can reduce some symptoms -- such as difficulties with memory, language, attention and reasoning -- especially in the early stages of the disease." However, "they don't work for everyone, and none of them works permanently."
        Researchers now targeting tau as well as beta-amyloid to develop new therapies . The Los Angeles Times (7/26, Adams) reports that researchers "studying treatments for Alzheimer's disease have focused on telltale plaques that appear in patients' diseased brains as a target for therapy. The plaques are clumps of a small protein called beta-amyloid that build up in the space around nerve cells and interfere with normal brain function." However, "earlier this month at an international conference, different tangled structures inside neurons took center stage alongside plaques. These so-called neurofibrillary tangles involve another protein, called tau, that normally functions to move critical supplies around neurons. Tau tangles are now being targeted with new experimental therapies."
        Researchers report progress on Alzheimer's blood test. The Houston Chronicle (7/25, Ackerman) reported, "Texas scientists are on the verge of developing a blood test to identify patients with Alzheimer's disease, a potential breakthrough on the difficult-to-diagnose ailment. The test, details of which were presented at an international conference on Alzheimer's in Hawaii this month, would give nonspecialists who often have trouble diagnosing the disease a tool to catch it earlier and make a referral when its progression can still be slowed. ... The study was the product of the Texas Alzheimer's Research Consortium, a Legislature-created collaboration that includes Baylor, Texas Tech, UT Southwestern Medical Center in Dallas, the UT Health Science Center at San Antonio and the University of North Texas Health Science Center in Fort Worth."
        Research in mice explores role sirtuin may play in Alzheimer's. The New York Times (7/24, A9, Wade) reported, "A potentially promising approach to treating Alzheimer's disease has been developed by researchers studying sirtuin, a protein thought capable of extending lifespan in laboratory animals." In fact, by "using mice prone to developing Alzheimer's, the researchers showed that activating sirtuin suppressed the disease and that destroying sirtuin made it much worse." The researchers from the "Massachusetts Institute of Technology...say it raises the hope of treating Alzheimer's, and possibly other neurodegenerative diseases like Parkinson's and Huntington's, with drugs that activate sirtuin." The Boston Globe (7/26, Weintraub) also covers the story.

Friday, July 23, 2010

Moral of the story: IBS may be due to the way the brain develops

Source: AMA Morning Rounds 7/23/2010


Scientists identify possible connection between IBS, brain.

The Los Angeles Times (7/22, Roan) "Booster Shots" blog reported that researchers from McGill University and UCLA have identified "a possible connection between IBS and the brain." After taking "MRI scans of 55 IBS patients and 48 healthy women for comparison," investigators noted that the "women with IBS tended to have different amounts of brain gray matter in certain areas; for example, decreases in gray matter in parts of the brain that govern attention and areas that suppress pain." That association has "been identified in other disorders, such as...fibromyalgia and hip pain," which suggests that IBS, "like these other conditions...may be due to the brain's inability to inhibit the pain response."

Monday, July 12, 2010

Brain decline reduced with activity, vitamin D and tea

Moral of the story:  This is a topic that many are trying to find information about, but answer are often conflicting.  Take this with a grain of salt, and if you are already doing everything great, otherwise it is up to you whether you want to drink more tea.  However, everyone should make sure they have normal levels of vitamin D and get enough physical activity (ideally 60 min every day).

Source: AMA Morning Rounds 7/12/2010


Physical activity, tea-drinking, sufficient vitamin D levels may help reduce risk of brain decline, studies suggest.

USA Today (7/12, Marcus) reports that, according to three studies presented at the Alzheimer's Association International Conference, "improved living and diet habits -- including lots of physical activity, regular tea-drinking and sufficient vitamin D levels -- could reduce the risk of brain decline." In a study following some 1,200 elderly individuals over two decades, investigators discovered that "participants who had moderate to heavy levels of physical activity had about a 40% lower risk of developing any type of dementia." A second study "including data on more than 4,800 men and women ages 65 and older" found that "those who drank tea one to four times a week had average annual rates of decline 37% lower than people who didn't drink tea."
        HealthDay (7/11, Preidt) reported that a third study that "analyzed data from 3,325 people aged 65 and older" found that "the risk of cognitive impairment was 42 percent higher

Monday, April 26, 2010

Computer brain games may not improve cognitive ability.

Moral of the story: Don't waste your money, but if you enjoy them, go for it.

Source: AMA Morning Rounds 4/21/2010

Computer brain games may not improve cognitive ability.


USA Today (4/21, Marcus) reports, "Computer brain games may not offer the big mental boost many were hoping for, suggests new research, but brain scientists and brain-game experts don't all agree on the findings." The study was published in Nature and "is the largest of its kind," its authors say. For the study, researchers recruited over "11,000 people between the ages of 18 and 60," who "were split into three groups, including two groups that played different brain-training games that are similar to commercially available games, and a control group that was asked to go online and find answers to questions about topics such as music." According to lead author Adrian Owen, "Participants did get better at games they practiced. The more they trained, the better they got. But there was still no translation to any general improvement in cognitive function."
        The Wall Street Journal (4/21, Naik) reports that companies which produce brain training and fitness games have experienced significant growth in the last few years, in part because of the increase in the number of baby boomers, and because previous research suggested that such games could benefit cognitive abilities. But, this six-week, online experiment has not borne out previous conclusions.

Wednesday, January 6, 2010

FDA investigates 300 radiation overdoses from CT scans.

Moral of the story: Just something to be aware of.  The CT might not be set correctly.

Source: AMA Morning Rounds 12/16/09

FDA investigates 300 radiation overdoses from CT scans.


NPR's (12/15, Neighmond) All Things Considered reported, "More than 300 patients may have received an overdose of radiation from a special type of CT scan used to image the brain. The Food and Drug Administration says the radiation overdoses occurred at three hospitals in Los Angeles County and one hospital in Huntsville, AL. FDA officials say there could be many more cases at hospitals nationwide as their investigation unfolds." Dr. Jeffrey Shuren, "acting director of the FDA's Center for Devices and Radiological Health," explained that "a regular CT scan to the brain is the equivalent of about 100 chest X-rays," whereas "a perfusion CT scan of the brain is equal to several hundred chest x-rays. Patients at the four hospitals who received excess radiation were exposed to the equivalent of several thousand X-rays instead -- three to eight times the expected radiation dose."

Tuesday, January 5, 2010

Bedside exam may be superior to CT in detecting post-brain surgery complications.

Moral of the story: CT is shown yet again to be less effective than originally thought, but will likely to continue to be gold standard because of litigation and societal desire for technology

Source: AMA Morning Rounds 12/29/09


Bedside exam may be superior to CT in detecting post-brain surgery complications.


HealthDay (12/28, Dotinga) reported that, according to a study appearing online in the Journal of Neurosurgery, "the low-cost, simple, but elegant neurological exam appears to be superior to a routine CT scan in determining return to the operating room" due to "post-brain surgery complications." A review of "the medical records of 251 patients who underwent CT scans within 24 hours of surgery" revealed that "the scans failed to show who would need to go back to the operating room." But, bedside exams showed "serious problems in 10 cases that required urgent CT scans; three of the patients needed to go back to the operating room."

Monday, January 4, 2010

Gingko biloba not effective in preventing cognitive decline, improving memory.

Moral of the story: Ginko is probably not worth buying for your mental health.

Source: AMA Morning Rounds 12/30/09; JAMA. 2009; 302:2663-2670


Gingko biloba not effective in preventing cognitive decline, improving memory.


The CBS Evening News (12/29, story 9, 0:20, Smith) reported, "Americans spend a quarter billion dollars a year on" gingko biloba supplements, "hoping to improve their memory and slow cognitive decline."
        NBC Nightly News (12/29, story 5, 2:00, Williams) reported that "now, a major study shows" that gingko biloba, "one of the most popular supplements, flat out does not work."
        USA Today (12/30, Weise) reports that, according to a study published in the Dec. 23-30 issue of the Journal of the American Medical Association, "the popular botanical...does not improve memory, nor does it prevent cognitive decline in older people." After analyzing data "from the Ginkgo Evaluation of Memory study" on "more than 3,000 people between ages 72 and 96 for seven years," researchers from the University of Virginia Medical School "found that a twice-daily dose of 120 milligrams of ginkgo biloba extract was not effective in reducing the incidence of Alzheimer's dementia or dementia overall."
        According to the Los Angeles Times (12/29, Kaplan) "Booster Shots" blog, the National Center for Complementary and Alternative Medicine, "a branch of the National Institutes of Health, has been researching ginkgo for 10 years to see whether the type of clinical trials required for FDA-regulated pharmaceuticals would reveal any benefit. The new findings are in line with several other studies, including a Cochrane review published this year that found 'no convincing evidence' that the herb preserves mental function in any way."
        The investigators "found no evidence that ginkgo delayed or prevented normal declines in memory, language, attention, visuospatial abilities, or executive functions, such as anticipating outcomes and adapting to changing situations and thinking abstractly," HealthDay (12/29, Reinberg) reported. Moreover, "these results remained the same regardless of sex, age, race or education," the investigators found. However, the supplement was found to be safe, "and no serious side effects were noted," study author Steven T. DeKosky, MD, said.
        WebMD (12/29, DeNoon) reported that "in a written statement," Douglas MacKay, ND, of the Council for Responsible Nutrition, "a group representing the supplement industry," said that "the DeKosky study 'should not be viewed as the final work' on ginkgo." He stated that "as a former practicing licensed naturopathic doctor," he "would continue to recommend ginkgo biloba to older adults as a safe, effective option for supporting cognitive health."

Ginkgo biloba for Preventing Cognitive Decline in Older Adults
A Randomized Trial
Beth E. Snitz, PhD; Ellen S. O’Meara, PhD; Michelle C. Carlson, PhD; Alice M. Arnold, PhD; Diane G. Ives, MPH; Stephen R. Rapp, PhD; Judith Saxton, PhD; Oscar L. Lopez, MD; Leslie O. Dunn, MPH; Kaycee M. Sink, MD; Steven T. DeKosky, MD; for the Ginkgo Evaluation of Memory (GEM) Study Investigators

JAMA. 2009;302(24):2663-2670.
Context  The herbal product Ginkgo biloba is taken frequently with the intention of improving cognitive health in aging. However, evidence from adequately powered clinical trials is lacking regarding its effect on long-term cognitive functioning.
Objective  To determine whether G biloba slows the rates of global or domain-specific cognitive decline in older adults.
Design, Setting, and Participants  The Ginkgo Evaluation of Memory (GEM) study, a randomized, double-blind, placebo-controlled clinical trial of 3069 community-dwelling participants aged 72 to 96 years, conducted in 6 academic medical centers in the United States between 2000 and 2008, with a median follow-up of 6.1 years.
Intervention  Twice-daily dose of 120-mg extract of G biloba (n = 1545) or identical-appearing placebo (n = 1524).
Main Outcome Measures  Rates of change over time in the Modified Mini-Mental State Examination (3MSE), in the cognitive subscale of the Alzheimer Disease Assessment Scale (ADAS-Cog), and in neuropsychological domains of memory, attention, visual-spatial construction, language, and executive functions, based on sums of z scores of individual tests.
Results  Annual rates of decline in z scores did not differ between G biloba and placebo groups in any domains, including memory (0.043; 95% confidence interval [CI], 0.034-0.051 vs 0.041; 95% CI, 0.032-0.050), attention (0.043; 95% CI, 0.037-0.050 vs 0.048; 95% CI, 0.041-0.054), visuospatial abilities (0.107; 95% CI, 0.097-0.117 vs 0.118; 95% CI, 0.108-0.128), language (0.045; 95% CI, 0.037-0.054 vs 0.041; 95% CI, 0.033-0.048), and executive functions (0.092; 95% CI, 0.086-0.099 vs 0.089; 95% CI, 0.082-0.096). For the 3MSE and ADAS-Cog, rates of change varied by baseline cognitive status (mild cognitive impairment), but there were no differences in rates of change between treatment groups (for 3MSE, P = .71; for ADAS-Cog, P = .97). There was no significant effect modification of treatment on rate of decline by age, sex, race, education, APOE*E4 allele, or baseline mild cognitive impairment (P > .05).
Conclusion  Compared with placebo, the use of G biloba, 120 mg twice daily, did not result in less cognitive decline in older adults with normal cognition or with mild cognitive impairment.
Trial Registration  clinicaltrials.gov Identifier: NCT00010803

Author Affiliations: Departments of Neurology (Drs Snitz, Saxton, Lopez, and DeKosky and Ms Dunn) and Epidemiology (Ms Ives), University of Pittsburgh, Pittsburgh, Pennsylvania; Department of Biostatistics, University of Washington, Seattle (Drs O’Meara and Arnold); Department of Mental Health, Johns Hopkins Medical Institutions, Baltimore, Maryland (Dr Carlson); Departments of Psychiatry and Behavioral Medicine (Dr Rapp) and Internal Medicine (Geriatrics/Gerontology), School of Medicine (Dr Sink), Wake Forest University, Winston-Salem, North Carolina; and School of Medicine, University of Virginia, Charlottesville (Dr DeKosky).

Wednesday, March 18, 2009

Metabolic disorders linked to cognitive decline

Moral of the story: Manage your chronic diseases! Stay on top of treatment, exercise and see your doctor. The last thing you want on top of diabetes is Alzheimer's disease.

Metabolic disorders linked to cognitive decline
March 17, 2009 Allison Gandey
Edited from Medscape Medical News—a professional news service of WebMD

New York, NY and Seattle, WA - Evidence is mounting that metabolic and neurological diseases share common risk factors, according to two studies in the March 2009 issue of the Archives of Neurology.
"Preventing heart disease, stroke, and diabetes—or making sure these conditions are well managed in patients diagnosed with them—can potentially slow the disease progression of Alzheimer's," senior author on one of the studies, Dr Yaakov Stern (Columbia University, New York), said in a news release. Stern et al, led by Dr Elizabeth Helzner (Columbia University) hypothesized that vascular factors such as heart disease, stroke, diabetes, hypertension, smoking, and blood lipid levels may predict the progression of Alzheimer's disease [1]. The group studied 156 patients followed for a mean of 3.5 years. Participants were from the Washington Heights and Inwood Columbia Aging Project, a multiethnic, community-based, prospective study of aging in northern Manhattan.
Researchers found that patients with a history of diabetes and elevated levels of cholesterol, especially LDL cholesterol, had faster cognitive decline. In fact, each 10-U increase in cholesterol and LDL cholesterol was associated with a 0.10-standard-deviation decrease in cognitive score per year of follow-up (p<0.001 for total cholesterol; p=0.001 for LDL cholesterol).
Investigators found that a history of heart disease and stroke were associated with cognitive decline only in carriers of the APOE e4 allele.
"These findings indicate that controlling vascular conditions may be one way to delay the course of Alzheimer's, which would be a major development in the treatment of this devastating disease," Stern said.Fluctuations in weight may boost dementia risk
In the second study published in the same issue of the Archives of Neurology, investigators show that obese middle-aged adults and underweight elderly people have an increased dementia risk [2].
Using data from the Cardiovascular Health Study, researchers studied the body-mass index (BMI) of participants at mid- and late life. Patients were from a community-dwelling sample at four US sites.
Investigators included 2798 people. Of these, 480 had incident dementia, 245 had Alzheimer's disease, and 213 had vascular dementia.
They found that middle-aged patients who were obese had an increased risk for dementia (BMI >30 vs normal-weight BMI 20 to 25), adjusted for demographics (hazard ratio 1.39; 95% CI 1.03-1.87), although this observation was weakened after adjustment for cardiovascular risk factors (hazard ratio 1.36; 95% CI 0.94-1.95).
These results help explain the 'obesity paradox.'
But the risk estimates were reversed in assessments of late-life BMI. Underweight people, those with a BMI of less than 20, had an increased risk for dementia (hazard ratio 1.62; 95% CI 1.02-2.64). Surprisingly, being overweight later in life was not associated with an increased risk (hazard ratio 0.92; 95% CI 0.72-1.18), and being obese reduced the risk for dementia (hazard ratio 0.63; 95% CI 0.44-0.91).
"These results help explain the 'obesity paradox,' " the researchers, led by Dr Annette Fitzpatrick (University of Washington, Seattle), write. "Differences in dementia risk across time are consistent with physical changes in the trajectory toward disability."
These findings suggest that the predictive ability of BMI changes across time, they note
"Weight loss occurs with comorbidities at older ages and is often reflective of poor health," write Fitzpatrick and her team. "Weight loss, along with psychological, behavioral, and mobility problems, is one of the principal manifestations of Alzheimer's disease. Weight loss may predate dementia onset by as much as 10 years."
The researchers conclude: "These results reinforce the necessity of monitoring weight loss closely in older adults."
The complete contents of Medscape Medical News, a professional news service of WebMD, can be found at www.medscape.com, a website for medical professionals.
Sources
Helzner EP, Luchsinger JA, Scarmeas N, et al. Contribution of vascular risk factors to the progression in Alzheimer disease. Arch Neurol 2009; 66:343-348.
Fitzpatrick AL, Kuller LH, Lopez OL, Midlife and late-life obesity and the risk of dementia: cardiovascular health study. Arch Neurol 2009; 66:336-342.
Related links
Adherence to Mediterranean diet reduces risk of major chronic diseases [Prevention > Prevention; Sep 12, 2008]
Heart disease linked to poor cognitive function in middle age [Brain/Kidney/Peripheral > Brain/Kidney/Peripheral; Jul 23, 2008]
Low HDL-C associated with poor memory [HeartWire > Brain/Kidney/Peripheral; Jun 30, 2008]
High cholesterol linked to increased AD risk [HeartWire > Medscape Medical News; Nov 06, 2006]
Low cholesterol linked to reduced cognitive function [HeartWire > News; Mar 23, 2005]
Lipid metabolism abnormalities observed in brain aging and Alzheimer's disease [HeartWire > News; Feb 15, 2004]

Friday, February 27, 2009

Green and Black Tea Consumption and Risk of Stroke. A Meta-Analysis

Moral of the story: Drinking black and green tea can help prevent a stroke. A meta-analysis is an analysis of all the literature on a single topic. This study found that taken all together, studies suggest that 3 cups of tea may be effective.

Green and Black Tea Consumption and Risk of Stroke. A Meta-Analysis

Lenore Arab PhD*;
Weiqing Liu MS; and David Elashoff PhD

From UCLA's School of Medicine, Los Angeles, Calif.

* To whom correspondence should be addressed. E-mail: Larab@ucla.edu.

Background and Purpose—Experimental models of stroke provide consistent evidence of smaller stroke volumes in animals ingesting tea components or tea extracts. To assess whether a similar association of black or green tea consumption with reduced risk is evident in human populations, we sought to identify and summarize all human clinical and observational data on tea and stroke.

Methods—We searched PubMed and Web of Science for all studies on stroke and tea consumption in humans with original data, including estimation or measurement of tea consumption and outcomes of fatal or nonfatal stroke. Data from 9 studies involving 4378 strokes among 194 965 individuals were pooled. The main outcome was the occurrence of fatal or nonfatal stroke. We tested for heterogeneity and calculated the summary effect estimate associated with consumption of ≥3 cups of tea (green or black) per day using random-effects and fixed-effects models for the homogeneous studies. Publication bias was also evaluated.

Results—Regardless of their country of origin, individuals consuming ≥3 cups of tea per day had a 21% lower risk of stroke than those consuming <1> 0.85). The proportion of heterogeneity not explained by chance alone was 23.8%.

Conclusions—Although a randomized clinical trial would be necessary to confirm the effect, this meta-analysis suggests that daily consumption of either green or black tea equaling 3 cups per day could prevent the onset of ischemic stroke.


Key words: black tea • Camelia sinensis • green tea • ischemic stroke • theophylline

Friday, December 19, 2008

Association of Alcohol Consumption With Brain Volume in the Framingham Study

Moral of the story: You have probably heard about the myth that drinking kills brain cells. Well, thanks to a very large heart study in Framinghman, MA that started back in 1948 we now know that drinking copious amounts of alcohol over an extended period of time will shrink the size of your brain. Thats right, the more you drink the smaller your brain will be (especially if you are female). The good news is that with limited amounts of alcohol your heart will be loving life, even if your brain isn't as lucky. However, there is also evidence that large quantities of alcohol are bad for your heart.


Association of Alcohol Consumption With Brain Volume in the Framingham Study
Carol Ann Paul, MS; Rhoda Au, PhD; Lisa Fredman, PhD; Joseph M. Massaro, PhD; Sudha Seshadri, MD; Charles DeCarli, MD; Philip A. Wolf, MD
Arch Neurol. 2008;65(10):1363-1367.
Background While adults who drink low to moderate amounts of alcohol have lower rates of cardiovascular disease than other adults, the effect of alcohol on the brain is less clear. There is evidence that drinking large amounts of alcohol is related to brain atrophy. It is uncertain what the effects of low to moderate consumption might be.
Objective To determine whether consumption of smaller amounts of alcohol negatively affects brain volume or is protective in reducing the well-documented age-related decline in brain volume.
Design Total cerebral brain volume (TCBV) was computed, correcting for head size. Multivariate linear regression models were used to evaluate the association between 5 categories of alcohol consumption (abstainers, former drinkers, low, moderate, high) and TCBV, adjusting for age, sex, education, height, body mass index (calculated as weight in kilograms divided by height in meters squared), and the Framingham Stroke Risk Profile. Pairwise comparisons were also conducted between the alcohol consumption groups.
Participants A total of 1839 subjects from the Framingham Offspring Study who had magnetic resonance imaging of the brain between 1999 and 2001.
Results Most participants reported low alcohol consumption, and men were more likely than women to be moderate or heavy drinkers. There was a significant negative linear relationship between alcohol consumption and TCBV (r = –0.25; P < .001). This relationship was modified by sex, with alcohol consumption having a stronger association with TCBV in women than in men (r = –0.29 vs –0.20). Conclusions In contrast to studies on cardiovascular disease, this study found that moderate alcohol consumption was not protective against normal age-related differences in total brain volume. Rather, the more alcohol consumed, the smaller the total brain volume.

Author Affiliations: Neuroscience Program, Wellesley College, Wellesley, Massachusetts (Ms Paul); Departments of Neurology (Drs Au, Seshadri, and Wolf), Epidemiology (Ms Paul and Dr Fredman), and Biostatistics, Boston University School of Public Health, Boston, Massachusetts (Dr Massaro); Department of Mathematics & Statistics, Boston University, Boston, Massachusetts (Dr Massaro); Framingham Heart Study, Framingham, Massachusetts (Drs Au, Massaro, Seshadri, and Wolf); and Department of Neurology and Center for Neuroscience, University of California, Davis, California (Dr DeCarli).